Sustained Virological Response After 4 Weeks of Telaprevir, Peginterferon, and Ribavirin in an Asian Patient with Genotype 1 Chronic Hepatitis C and IL28B Genotype CC

被引:0
作者
Brulotte, Natalie [1 ]
Hahn, Hejin [2 ]
Lee, Maximilian [1 ]
机构
[1] Virginia Mason Med Ctr, Inst Digest Dis, Seattle, WA 98101 USA
[2] Virginia Mason Med Ctr, Dept Pathol & Lab Med, Seattle, WA 98101 USA
关键词
INFECTION; UPDATE;
D O I
10.1007/s10620-013-2903-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:737 / 739
页数:3
相关论文
共 6 条
[1]   100% SVR IN IL28B CC PATIENTS TREATED WITH 12 WEEKS OF TELAPREVIR, PEGINTERFERON AND RIBAVIRIN IN THE PROVE2 TRIAL [J].
Bronowicki, J-P ;
Hezode, C. ;
Bengtsson, L. ;
Pol, S. ;
Bourliere, M. ;
Serfaty, L. ;
de Ledinghen, V. ;
Tran, A. ;
Benhamou, Y. ;
Grange, J-D ;
Mathurin, P. ;
Marcellin, P. ;
Trepo, C. ;
Zarski, J-P ;
Seepersaud, S. ;
Kelliher, K. ;
Botfield, M. ;
Pawlotsky, J-M .
JOURNAL OF HEPATOLOGY, 2012, 56 :S430-S431
[2]   IL28B Genomic-Based Treatment Paradigms for Patients With Chronic Hepatitis C Infection: The Future of Personalized HCV Therapies [J].
Clark, Paul J. ;
Thompson, Alex J. ;
McHutchison, John G. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (01) :38-45
[3]   Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance [J].
Ge, Dongliang ;
Fellay, Jacques ;
Thompson, Alexander J. ;
Simon, Jason S. ;
Shianna, Kevin V. ;
Urban, Thomas J. ;
Heinzen, Erin L. ;
Qiu, Ping ;
Bertelsen, Arthur H. ;
Muir, Andrew J. ;
Sulkowski, Mark ;
McHutchison, John G. ;
Goldstein, David B. .
NATURE, 2009, 461 (7262) :399-401
[4]   An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases [J].
Ghany, Marc G. ;
Nelson, David R. ;
Strader, Doris B. ;
Thomas, David L. ;
Seeff, Leonard B. .
HEPATOLOGY, 2011, 54 (04) :1433-1444
[5]   Diagnosis, Management, and Treatment of Hepatitis C: An Update [J].
Ghany, Marc G. ;
Strader, Doris B. ;
Thomas, David L. ;
Seeff, Leonard B. .
HEPATOLOGY, 2009, 49 (04) :1335-1374
[6]   Second-Phase Hepatitis C Virus RNA Decline During Telaprevir-Based Therapy Increases With Drug Effectiveness: Implications for Treatment Duration [J].
Guedj, Jeremie ;
Perelson, Alan S. .
HEPATOLOGY, 2011, 53 (06) :1801-1808